By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

BioAdaptives, Inc. (BDPT)

OTC Currency in USD
$0.03
$0.00
+0.53%
Last Update: 9 Sept 2025, 19:33
$300.05K
Market Cap
-0.75
P/E Ratio (TTM)
Forward Dividend Yield
$0.01 - $0.18
52 Week Range

BDPT Stock Price Chart

Explore BioAdaptives, Inc. interactive price chart. Choose custom timeframes to analyze BDPT price movements and trends.

BDPT Company Profile

Discover essential business fundamentals and corporate details for BioAdaptives, Inc. (BDPT) to support your stock research and investment decisions.

Sector

Consumer Defensive

Industry

Packaged Foods

IPO Date

9 Jul 2014

Employees

1.00

CEO

James E. Keener

Description

BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

BDPT Financial Timeline

Browse a chronological timeline of BioAdaptives, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Stock split effective on 23 Jan 2025

Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Jun 2023

EPS came in at -$0.00 , while revenue for the quarter reached $2.34K .

Earnings released on 31 Mar 2023

EPS came in at -$0.00 , while revenue for the quarter reached $3.38K .

Earnings released on 31 Dec 2022

EPS came in at $0.00 , while revenue for the quarter reached $3.98K .

Earnings released on 30 Sept 2022

EPS came in at -$0.00 , while revenue for the quarter reached $3.34K .

Earnings released on 30 Jun 2022

EPS came in at -$0.00 , while revenue for the quarter reached $4.32K .

Earnings released on 31 Mar 2022

EPS came in at -$0.01 , while revenue for the quarter reached $5.53K .

Earnings released on 31 Dec 2021

EPS came in at -$0.01 , while revenue for the quarter reached $3.85K .

Earnings released on 30 Sept 2021

EPS came in at -$0.00 , while revenue for the quarter reached $5.34K .

Earnings released on 30 Jun 2021

EPS came in at -$0.01 , while revenue for the quarter reached $6.07K .

Earnings released on 31 Mar 2021

EPS came in at -$0.02 , while revenue for the quarter reached $4.52K .

Earnings released on 31 Dec 2020

EPS came in at -$0.01 , while revenue for the quarter reached $3.73K .

Earnings released on 30 Sept 2020

EPS came in at -$0.00 , while revenue for the quarter reached $4.44K .

BDPT Stock Performance

Access detailed BDPT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run